Syros Pharmaceuticals Statistics
Total Valuation
SYRS has a market cap or net worth of $135.97 million. The enterprise value is $60.11 million.
| Market Cap | 135.97M |
| Enterprise Value | 60.11M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SYRS has 26.45 million shares outstanding. The number of shares has increased by 124.24% in one year.
| Shares Outstanding | 26.45M |
| Shares Change (YoY) | +124.24% |
| Shares Change (QoQ) | +5.59% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 81.58% |
| Float | 11.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.06 |
| Forward PS | 47.55 |
| PB Ratio | 8.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.95, with a Debt / Equity ratio of 3.73.
| Current Ratio | 3.95 |
| Quick Ratio | n/a |
| Debt / Equity | 3.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.10 |
Financial Efficiency
Return on equity (ROE) is -282.60% and return on invested capital (ROIC) is -163.82%.
| Return on Equity (ROE) | -282.60% |
| Return on Assets (ROA) | -93.70% |
| Return on Capital (ROIC) | -163.82% |
| Revenue Per Employee | $146,118 |
| Profits Per Employee | -$2.42M |
| Employee Count | 68 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.74% in the last 52 weeks. The beta is 1.78, so SYRS's price volatility has been higher than the market average.
| Beta (1Y) | 1.78 |
| 52-Week Price Change | +81.74% |
| 50-Day Moving Average | 6.20 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 45.01 |
| Average Volume (30 Days) | 213,908 |
Short Selling Information
The latest short interest is 1.82 million, so 6.89% of the outstanding shares have been sold short.
| Short Interest | 1.82M |
| Short Previous Month | 1.74M |
| Short % of Shares Out | 6.89% |
| Short % of Float | 16.18% |
| Short Ratio (days to cover) | 9.18 |
Income Statement
In the last 12 months, SYRS had revenue of $9.94 million and -$164.57 million in losses. Loss per share was -$5.81.
| Revenue | 9.94M |
| Gross Profit | 9.94M |
| Operating Income | -128.99M |
| Pretax Income | -164.57M |
| Net Income | -164.57M |
| EBITDA | -157.12M |
| EBIT | -159.45M |
| Loss Per Share | -$5.81 |
Balance Sheet
The company has $141.65 million in cash and $62.08 million in debt, giving a net cash position of $79.57 million or $3.01 per share.
| Cash & Cash Equivalents | 141.65M |
| Total Debt | 62.08M |
| Net Cash | 79.57M |
| Net Cash Per Share | $3.01 |
| Equity / Book Value | 16.66M |
| Book Value Per Share | 0.63 |
| Working Capital | 108.30M |
Cash Flow
In the last 12 months, operating cash flow was -$109.71 million and capital expenditures $1.29 million, giving a free cash flow of -$108.42 million.
| Operating Cash Flow | -109.71M |
| Capital Expenditures | 1.29M |
| Free Cash Flow | -108.42M |
| FCF Per Share | -$3.83 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,298.19% and -1,656.34%.
| Gross Margin | 100.00% |
| Operating Margin | -1,298.19% |
| Pretax Margin | -1,656.34% |
| Profit Margin | -1,656.34% |
| EBITDA Margin | -1,581.31% |
| EBIT Margin | -1,604.74% |
| FCF Margin | -1,091.17% |
Dividends & Yields
SYRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -124.24% |
| Shareholder Yield | -124.24% |
| Earnings Yield | -117.83% |
| FCF Yield | -77.62% |
Analyst Forecast
The average price target for SYRS is $14.33, which is 177.18% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.33 |
| Price Target Difference | 177.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 145.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 19, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SYRS has an Altman Z-Score of -7.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.76 |
| Piotroski F-Score | 2 |